Literature DB >> 17210526

Increased culture recovery of Zygomycetes under physiologic temperature conditions.

Dimitrios P Kontoyiannis1, Georgios Chamilos, Saad A Hassan, Russell E Lewis, Nathaniel D Albert, Jeffrey J Tarrand.   

Abstract

Poor recovery of Zygomycetes hyphae from tissue specimens may result from failure of current culture methods to mimic physiologic conditions found in hyphae-laden infected tissue. We describe the use of an in vitro model simulating Zygomycetes growth under necrotic or hypoxic tissue conditions. We preconditioned hyphae of clinical Zygomycetes isolates in flasks under anaerobic conditions using Ana-Packs (Becton Dickinson Microbiology Systems, Sparks, MD) at 37 degrees C for 48 hours, thus simulating in vivo growth in an infracted hypoxic lesion, and compared the recovery of paired inocula at 37 degrees C and 25 degrees C. Incubation of stock culture isolates at 37 degrees C resulted in significantly better culture recovery (about 10-fold) when compared with incubation at 25 degrees C (P < .0001). In addition, we similarly evaluated 25, 291 consecutive clinical specimens. Among 41 specimens, the yield of Zygomycetes cultures incubated at 37 degrees C (23/41 [56%]) was significantly higher than that incubated at 25 degrees C (9/41 [22%]; P = .0001). Overall, we found that culture recovery was significantly (254%) enhanced at 37 degrees C.

Entities:  

Mesh:

Year:  2007        PMID: 17210526     DOI: 10.1309/7KU5XWURYM0151YN

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

1.  Molecular Detection of Filamentous Fungi in Formalin-Fixed Paraffin-Embedded Specimens in Invasive Fungal Wound Infections Is Feasible with High Specificity.

Authors:  Anuradha Ganesan; Justin Wells; Faraz Shaikh; Philip Peterson; William Bradley; M Leigh Carson; Joseph L Petfield; Mary Klassen-Fischer; Kevin S Akers; Kevin Downing; Ralf Bialek; David R Tribble; Brian L Wickes
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

Review 2.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Future directions in mucormycosis research.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis; Oliver Lortholary; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roilides; Emmanuel Roillides; Ashraf Ibrahim; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 4.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

5.  Glucocorticosteroids do not impact directly growth rate and biomass of Rhizopus arrhizus (syn. R. oryzae) in vitro.

Authors:  A P Bellanger; Y D Minetos; N Albert; F Shirazi; T J Walsh; D P Kontoyiannis
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 6.  How I treat mucormycosis.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

Review 7.  Tracheobronchial mycosis in a retrospective case-series study of five status asthmaticus patients.

Authors:  Garbo Mak; Paul C Porter; Venkata Bandi; Farrah Kheradmand; David B Corry
Journal:  Clin Immunol       Date:  2012-11-27       Impact factor: 3.969

8.  Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis.

Authors:  Miki Kasai; Susan M Harrington; Andrea Francesconi; Vidmantas Petraitis; Ruta Petraitiene; Mara G Beveridge; Tena Knudsen; Jeffery Milanovich; Margaret P Cotton; Johanna Hughes; Robert L Schaufele; Tin Sein; John Bacher; Patrick R Murray; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

Review 9.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

10.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.